@4040rec.bsky.social
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more news.. statnews.com/pharmalot/20... #pharma #obesity #antibiotic #jobs #China #weight #Novo #Roche #Merck #AstraZeneca #Baltimore #Bausch
@pharmaphorum.bsky.social#AstraZeneca has taken a roughly 10% stake in Summit Therapeutics for $2bn, signing a deal to test CLDN18.2-targeting #ADC sone-ve with PD-1xVEGF bispecific ivonescimab.
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about a reticent FDA commish nominee, a Novo deal, and more news.. statnews.com/pharmalot/20... #pharma #FDA #Overton #Lilly #Novo #AstraZeneca #patents #Indonesia
@pharmaphorum.bsky.social#AstraZeneca could be just months away from #FDA approval of a new #bladdercancer indication for its #PDL1inhibitor #Imfinzi, which is viewed as key to meeting its sales ambitions for the drug.
@top10grid.bsky.socialNo. 1 in technology: AstraZeneca. Top 10 European Pharmaceutical Tech Companies. https://top10grid.com/top-10-european-pharmaceutical-tech-companies?utm_source=bluesky&utm_medium=social&utm_campaign=video-distribution #astrazeneca #novartis #roche
@pharmafakten.bsky.socialDie Geschichte der #Krebsmedizin ist die Geschichte eines immer tieferen Verständnisses der Erkrankung. Darüber spricht Dr. Niko Andre, Mediziner und Leiter des #Onkologie-Bereiches beim forschenden #Pharmaunternehmen #AstraZeneca in Deutschland, in einem Podcast: pharma-fakten.de/news/krebsfo...
@pharmaphorum.bsky.social#AstraZeneca's rare disease unit #Alexion has claimed a positive opinion from the #EMA's human medicines committee for #generalisedmyastheniagravis (gMG) therapy #Klygefa.
@4040rec.bsky.social@pharmaphorum.bsky.socialAround 1,000 patients in #England with a form of incurable #breastcancer will be able to get access to #AstraZeneca and #DaiichiSankyo's life-extending drug, #Enhertu, via the #NHS from today.
@6iccom.bsky.socialSince 2022, the UK’s Vaccine Damage Payment Scheme has spent more than twice as much on administration as it has paid out to claimants, sparking calls for a review.
#health #AstraZeneca
@wordquad.bsky.social#AstraZeneca 's cancer pipeline posts two wins and a loss
#ENHERTU and #TAGRISSO Show Promise Despite #Etcamah Setbacks
@wordquad.bsky.social#AstraZeneca ’s newly approved pill fails frontline breast cancer study
#Etcamah is the second oral “SERD” to recently fall short in first-line breast cancer, following a similar setback from #Roche earlier this year.
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about another AstraZeneca trial failure, a Novo name change, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #Medicaid #NovoNordisk #pollution #weightloss #muscle #AstraZeneca
@pharmaphorum.bsky.socialJust a week after getting FDA approval as a frontline treatment for HR-positive, HER2-negative #breastcancer, #AstraZeneca's #Etcamah has missed the mark in a trial designed to expand its label.
@agentictribune.bsky.socialDurvalumab Plus FLOT Boosts Survival in Resectable Gastric and GEJ Cancer, MATTERHORN Shows
#oncology #immunotherapy #durvalumab #gastric-cancer #astrazeneca
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more news.. statnews.com/pharmalot/20... #pharma #FDA #COPD #tariffs #HIV #weight #obesity #Lilly #AstraZeneca #SouthAfrica
@quartzmedia.bsky.socialICYMI: AstraZeneca's new COPD drug works where others can't #AstraZeneca #COPD
@pharmaphorum.bsky.socialThe #FDA has started a #priorityreview of #AstraZeneca's IL-33-targeting antibody #tozorakimab for chronic obstructive pulmonary disease (#COPD), setting up a decision on the would-be blockbuster in the first quarter of 2027.
@quartzmedia.bsky.socialAstraZeneca's new COPD drug works where others can't #AstraZeneca #COPD